Serious lymphocytic leukemia (CLL) is usually a lymphoid malignancy characterized through the proliferation and accumulation of experienced CD5+ B cells from the blood, bone marrow and lymphoid tissues. The diagnosis of CLL calls for the existence of ≥five x109/L mono - clonal B cells of regular